Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

A liquid fraction of extracellular matrix inhibits glioma cell viability in vitro and in vivo

Oncotarget(2022)10.18632/oncotarget.28203Source: DataRank Database

A liquid fraction of extracellular matrix inhibits glioma cell viability in vitro and in vivo is a research paper published in Oncotarget (2022). On theSindex it has a DataRank of 0. It has been cited 2 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access2 citations

Download PDF

Cite:

Linked data & code

nct

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (5 grants)Impact (FWCI 0.42)OA: goldTopics (52)IDs (PubMed, PMC, OpenAlex)Annotations (1)SDGs (2)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (11)

George S. Hussey ORCID,Jordan Chang ORCID,Ryan C. Hill ORCID,David Nascari ORCID,Aparna Rao ORCID

Live enrichment

PubMed:35198102 PMC:PMC8860176 OpenAlex:https://openalex.org/W4213037652

NCI NIH HHS

Grant: P30 CA047904

NCATS NIH HHS

Grant: TL1 TR001858

NIH HHS

Grant: S10 OD021641

National Institutes of Health

Grant: 3TL1TR001858-07S1

Administrative Supplement to NIH-funded TL1 Training Grants

National Institutes of Health

Grant: 3P30CA047904-07S1

CANCER CENTER SUPPORT GRANT

FWCI

0.42

Citation Percentile

0.6%

Citation Trend

2025

goldLicense: cc-by

journalhttps://doi.org/10.18632/oncotarget.28203

publisherhttps://doi.org/10.18632/oncotarget.28203

publisherhttps://www.oncotarget.com/lookup/doi/10.18632/oncotarget.28203

repositoryhttps://pubmed.ncbi.nlm.nih.gov/35198102

repositoryhttps://www.ncbi.nlm.nih.gov/pmc/articles/8860176

Fields of Study

Tissue Engineering and Regenerative MedicineElectrospun Nanofibers in Biomedical ApplicationsGraphene and Nanomaterials Applications0301 basic medicine0303 health sciences03 medical and health sciences0302 clinical medicineAnimalsBrain NeoplasmsCell Line, TumorCell SurvivalExtracellular MatrixGlioblastomaGliomaRatsRats, Sprague-DawleyRats, Wistar

MeSH Terms

AnimalsBrain NeoplasmsCell SurvivalExtracellular MatrixGlioblastomaGliomaRats, Sprague-DawleyRats, WistarCell Line, TumorRats

Keywords

In vivoExtracellular matrixIn vitroViability assayGliomaMedicineCancer researchChemistryCell biologyBiologyBiochemistryGeneticsBrain cancerTissue Organization Field TheoryGlioma TreatmentDynamic ReciprocityBrain NeoplasmsCell SurvivalRatsRats, Sprague-DawleyCell Line, TumorAnimalsRats, WistarGlioblastomaResearch Paper

Sustainable Development Goals

SDG 3: 3. Good healthSDG 0: Good health and well-being

A liquid fraction of extracellular matrix inhibits glioma cell viability in vitro and in vivo

FAIR Checklist

Authors (11)

Funding (5 grants)

Impact

Open Access

Topics

Annotations (Europe PMC)